L26/P-530 Placenta pathology results in livebirths conceived with in vitro fertilization after day 5 versus day 6 frozen embryo transfers
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.863 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von I. Dimitriadis und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does the timing of blastocyst cryopreservation for transfer (Day 5 versus Day 6) influence placental pathology outcomes in cryothaw cycles that result in singleton deliveries? Summary answer Among singleton cryothaw conceptions, placental pathology outcomes are not influenced by whether blastocysts were cryopreserved on Day 5 or Day 6. What is known already The availability and use of frozen embryos after ovarian hyperstimulation for assisted reproduction have increased with improvements in vitrification techniques. Frozen embryo transfers (FETs) have been associated with a higher risk of placental pathology and placenta-mediated adverse pregnancy outcomes, including hypertensive disorders of pregnancy. With advances in embryo culture conditions, patients can utilize day 5, day 6, and even day 7 blastocysts. Delayed blastocyst development has been associated with reduced viability and adverse pregnancy outcomes. However, the specific effect of blastocyst developmental timing on placental pathology remains unknown. Study design, size, duration This retrospective cohort study analyzed placental pathology from 162 singleton livebirths conceived via IVF between 2015 and 2023. Only patients with FETs and available placental pathology data were included. Placental pathology was reviewed by a single expert perinatal pathologist. Abnormalities were classified as anatomic, inflammatory, infectious, and vascular, using the Amsterdam Workshop Consensus for definitions. Participants/materials, setting, methods Placental pathologies were compared between patients with day 5 (D5ET, n = 74) vs. day 6 FET (D6ET, n = 88). Setting: Academic fertility center Primary outcomes were placental abnormalities classified as: anatomic, inflammatory, infectious, and vascular. Statistics: Parametric and non-parametric tests were performed as appropriate. Logistic regression models were performed controlling for maternal age, body mass index (BMI), and gestational age at delivery. Main results and the role of chance Mean age, BMI, ovarian reserve markers, and race were comparable between the two groups. Overall, there were no significant differences in the infertility diagnoses, except for diminished ovarian reserve which was more common in D5ET (24% vs. 6%, p < 0.001; D5ET vs. D6ET, respectively) and idiopathic infertility which was more common in D6ET (15% vs. 30%, p = 0.027; D5ET vs. D6ET, respectively). There was no significant difference in mean (SD) placental weight (g) at time of delivery [443.4 (117.5) vs. 476.3 (119.7), p = 0.082; D5ET vs. D6ET, respectively]. Unadjusted analysis showed no differences in anatomic, infectious, inflammatory, and vascular abnormalities between the two groups (64% vs. 67%, p = 0.64; 31% vs. 35%, p = 0.58; 27% vs. 20%, p = 0.33; 77% vs. 72%, p = 0.43, D5ET vs. D6ET, respectively). Similarly, when adjusting for maternal age, body mass index (BMI), and gestational age at delivery, there were no differences between D5ET and D6ET in anatomic, infectious, inflammatory, and vascular abnormalities [aOR (95%CI), anatomic: 1.14 (0.59-2.21); infectious: 1.27 (0.65-2.50); inflammatory: 0.74 (0.35-1.55); vascular: 0.79 (0.38-1.63)]. Limitations, reasons for caution There are the inherent limitations of retrospective study design. Further limitations include the limited sample size and the lack of more extensive clinical characteristics other than baseline demographics and gestational age at delivery that could further impact placenta pathology. Wider implications of the findings In our study, there was no association between the day of blastocyst cryopreservation and placental pathology. One additional day in culture media does not appear to impact placenta pathology in FET livebirths. Further research is warranted to confirm these findings in fresh embryo transfers and correlate with other clinical implications. Trial registration number No
Zitieren
APA
Dimitriadis, I., Vagios, S., Cherouveim, P., James, K., Arkfeld, C., Sassin, A., Minis, E., Bormann, C., Roberts, D., & Souter, I. (2026). L26/P-530 Placenta pathology results in livebirths conceived with in vitro fertilization after day 5 versus day 6 frozen embryo transfers. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.863
Vancouver
Dimitriadis I, Vagios S, Cherouveim P, James K, Arkfeld C, Sassin A, et al. L26/P-530 Placenta pathology results in livebirths conceived with in vitro fertilization after day 5 versus day 6 frozen embryo transfers. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.863
BibTeX
@article{Dimitriadis2026,
author = {Dimitriadis, I. and Vagios, S. and Cherouveim, P. and James, K. and Arkfeld, C. and Sassin, A. and Minis, E. and Bormann, C. and Roberts, D. and Souter, I.},
title = {L26/P-530 Placenta pathology results in livebirths conceived with in vitro fertilization after day 5 versus day 6 frozen embryo transfers},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.863}
}
EUVIMED